Higher-grade transformation of follicular lymphoma – a continuous enigma (original) (raw)
References
Davies AJ, Lee AM, Taylor C, Clear AJ, Gogg LK, Iqbal S et al. A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 2005; 19, 1459–1465. ArticleCAS Google Scholar
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392. CASPubMed Google Scholar
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849. ArticleCAS Google Scholar
Lossos IS, Levy R . Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 2003; 13: 191–202. ArticleCAS Google Scholar
Acker B, Hoppe RT, Colby TV, Cox RS, Kaplan HS, Rosenberg SA . Histologic conversion in the non-Hodgkin's lymphomas. J Clin Oncol 1983; 1: 11–16. ArticleCAS Google Scholar
Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 1997; 15: 1587–1594. ArticleCAS Google Scholar
Ersboll J, Schultz HB, Pedersen-Bjergaard J, Nissen NI . Follicular low-grade non-Hodgkin's lymphoma: long-term outcome with or without tumor progression. Eur J Haematol 1989; 42: 155–163. ArticleCAS Google Scholar
Lossos IS, Levy R . Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene. Blood 2000; 96: 635–639. CASPubMed Google Scholar
Matolcsy A, Casali P, Warnke RA, Knowles DM . Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 1996; 88: 3937–3944. CASPubMed Google Scholar
Pinyol M, Cobo F, Bea S, Jares P, Nayach I, Fernandez PL et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood 1998; 9: 2977–2984. Google Scholar
Elenitoba-Johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M . Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 1998; 91: 4677–4685. CASPubMed Google Scholar
Villuendas R, Sanchez-Beato M, Martinez JC, Saez AI, Martinez-Delgado B, Garcia JF et al. Loss of p16/INK4A protein expression in non-Hodgkin's lymphomas is a frequent finding associated with tumor progression. Am J Pathol 1998; 153: 887–897. ArticleCAS Google Scholar
Yano T, Jaffe ES, Longo DL, Raffeld M . MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758–767. CASPubMed Google Scholar
Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ et al. Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci USA 2002; 99: 8886–8891. ArticleCAS Google Scholar
Elenitoba-Johnson KS, Jenson SD, Abbott RT, Palais RA, Bohling SD, Lin Z et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc Natl Acad Sci USA 2003; 100: 7259–7264. ArticleCAS Google Scholar
Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R . p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289–2295. CASPubMed Google Scholar
Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES et al. p53 mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994–2004. CASPubMed Google Scholar
Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 1991; 88: 5413–5417. ArticleCAS Google Scholar
Koduru PR, Raju K, Vadmal V, Menezes G, Shah S, Susin M et al. Correlation between mutation in P53, p53 expression, cytogenetics, histologic type, and survival in patients with B-cell non-Hodgkin's lymphoma. Blood 1997; 90: 4078–4091. CASPubMed Google Scholar
Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K et al. Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma. N Engl J Med 1997; 337: 529–534. ArticleCAS Google Scholar
Chen PM, Chiou TJ, Hsieh RK, Fan FS, Chu CJ, Lin CZ et al. p53 gene mutations and rearrangements in non-Hodgkin's lymphoma. Cancer 1999; 85: 718–724. ArticleCAS Google Scholar
Pagnano KB, Vassallo J, Lorand-Metze I, Costa FF, Saad ST . p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas. Am J Hematol 2001; 67: 84–92. ArticleCAS Google Scholar
Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T et al. The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood 1994; 84: 3158–3165. CASPubMed Google Scholar
Akasaka T, Lossos IS, Levy R . BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 2003; 102: 1443–1448. ArticleCAS Google Scholar
Phan RT, Dalla-Favera R . The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432: 635–639. ArticleCAS Google Scholar
Lossos IS, Thorstenson YR, Wayne TL, Oefner P, Levy R, Chu G . Mutation of the ATM gene is not involved in the pathogenesis of either follicle center lymphoma or its transformation to higher-grade lymphoma. Leukemia Lymphoma 2002; 43: 1079–1085. ArticleCAS Google Scholar